I studied docking interaction of new organic compounds with CYP3A4 and obtained some good interactions compared to Gemcitabine.

While studying in vitro activity, which cell line should I choose? Breast cancer or liver cancer?

More Sachin Wazalwar's questions See All
Similar questions and discussions